Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
When the closely-watched SpaceX IPO fina...
Senate Majority Leader John Thune, R-S.D...
Israeli special ops veteran Aaron Cohen ...
Joe Lavorgna, SMBC Americas Managing Dir...
Sarah Kunst, Cleo Capital founder and ma...
A weekly, midday program that delivers h...
‘The Big Money Show’ panelists debate wh...
"The only option is to win. Trump has to...
Helima Croft, RBC Capital Markets, joins...
Bret Taylor, OpenAI chairman and Sierra ...
